loratadine has been researched along with Hypoxia in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaabani, E | 1 |
| Sharifiaghdam, M | 1 |
| Lammens, J | 1 |
| De Keersmaecker, H | 1 |
| Vervaet, C | 1 |
| De Beer, T | 1 |
| Motevaseli, E | 1 |
| Ghahremani, MH | 1 |
| Mansouri, P | 1 |
| De Smedt, S | 1 |
| Raemdonck, K | 1 |
| Faridi-Majidi, R | 1 |
| Braeckmans, K | 1 |
| Fraire, JC | 1 |
1 other study available for loratadine and Hypoxia
| Article | Year |
|---|---|
Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape.
Topics: Angiogenesis Inducing Agents; Animals; Cell Survival; Chemical Phenomena; Diabetic Angiopathies; Dru | 2021 |